3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Thoracic
1
Other
1
Conditions
Breast Neoplasms
21
Head and Neck Neoplasms
17
Prostatic Neoplasms
15
Neoplasms
12
Lung Neoplasms
12
Radiation Injuries
9
Esophageal Neoplasms
8
Rectal Neoplasms
7
Glioma
7
Brain Neoplasms
7
Glioblastoma
6
Carcinoma, Non-Small-Cell Lung
6
Uterine Cervical Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Neoplasm Metastasis
5
Carcinoma, Hepatocellular
4
Stomach Neoplasms
3
Colorectal Neoplasms
3
Central Nervous System Neoplasms
3
Astrocytoma
3
Xerostomia
2
Urinary Bladder Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma
2
Salivary Gland Neoplasms
2
Pelvic Neoplasms
2
Osteoradionecrosis
2
Lymphedema
2
Kidney Neoplasms
2
Esthesioneuroblastoma, Olfactory
2
Interventions
Surveys and Questionnaires
5
Therapeutics
3
Psychiatric Rehabilitation
2
trametinib
1
sotorasib
1
selpercatinib
1
pembrolizumab
1
osimertinib
1
lorlatinib
1
dabrafenib
1
cemiplimab
1
brigatinib
1
alectinib
1
Uterine Myomectomy
1
Surgical Procedures, Operative
1
Radiotherapy
1
Pemetrexed
1
Paclitaxel
1
Nivolumab
1
Low Density Lipoprotein Receptor-Related Protein-1
1
Interviews as Topic
1
High-Energy Shock Waves
1
Focus Groups
1
Drug Therapy
1
Carboplatin
1
Anti-Inflammatory Agents, Non-Steroidal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Sexual Dysfunction, Physiological
×
Radiotherapy
×
Clear all
NCT06018376
2026-02-06
LUDICAS
Fundación GECP
Completed
553 enrolled
6 charts